PTCT:PTC Therapeutics, Inc. Snapshot | Charting | News | Options
$65.03   0.00%  $0.00 NASDAQ 7:00a ET
November 3 '26 		PTC Therapeutics Board of Directors Authorizes $500 Million Share Repurchase Program PR Newswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on PTCT
    No News Available
    PTC Therapeutics to Participate in Upcoming Investor Conferences
    8:00a ET November 2 '26 PR Newswire
    PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule ...
    4:30p ET October 30 '26 PR Newswire
    PTC Therapeutics Provides Corporate Update and Reports Third Quarter ...
    4:01p ET October 29 '26 PR Newswire
    PTC Therapeutics to Report Third Quarter 2026 Financial Results on Th...
    8:01a ET October 15 '26 PR Newswire
    PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule ...
    4:30p ET September 25 '26 PR Newswire
    PTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy
    4:30p ET September 21 '26 PR Newswire
    PTC Therapeutics to Participate in Upcoming Investor Conferences
    8:02a ET August 27 '26 PR Newswire
    PTC Therapeutics to Participate in Upcoming Investor Conferences
    8:00a ET August 27 '26 PR Newswire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.